|
SLC38A7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.603030E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.226240E-01 |
| Normal-vs-Stage2 |
2.094300E-02 |
| Normal-vs-Stage3 |
1.485820E-02 |
| Normal-vs-Stage4 |
9.033200E-01 |
| Stage1-vs-Stage2 |
6.482000E-02 |
| Stage1-vs-Stage3 |
4.376500E-02 |
| Stage1-vs-Stage4 |
6.660200E-01 |
| Stage2-vs-Stage3 |
7.613600E-01 |
| Stage2-vs-Stage4 |
1.188770E-01 |
| Stage3-vs-Stage4 |
4.971700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.124200E-03 |
| Normal-vs-AfricanAmerican |
4.294400E-02 |
| Normal-vs-Asian |
2.473600E-01 |
| Caucasian-vs-AfricanAmerican |
9.949600E-01 |
| Caucasian-vs-Asian |
3.237000E-01 |
| AfricanAmerican-vs-Asian |
3.254400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.041700E-03 |
| Normal-vs-Female |
8.24530000000934E-05 |
| Male-vs-Female |
1.494060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.537800E-01 |
| Normal-vs-Extreme_Weight |
2.982000E-01 |
| Normal-vs-Obese |
1.216340E-02 |
| Normal-vs-Extreme_Obese |
1.370010E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.054400E-01 |
| Normal_Weight-vs-Obese |
9.191600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.090200E-01 |
| Extreme_Weight-vs-Obese |
1.494580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.528430E-01 |
| Obese-vs-Extreme_Obese |
4.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.108080E-02 |
| Normal-vs-Age(41-60Yrs) |
4.196900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.077900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.936000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.178200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.234600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.379610E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.772600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.194000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.528500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.808000E-02 |
| Normal-VS-Type2 PRCC |
2.244500E-03 |
| Normal-VS-KIRP CIMP |
4.226100E-02 |
| Normal-VS-Unclassified PRCC |
1.789510E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.474200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.155800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.818100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.204800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.358400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.589000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.628100E-02 |
| Normal-vs-N1 |
3.331900E-02 |
| Normal-vs-N2 |
3.812600E-01 |
| N0-vs-N1 |
9.019000E-01 |
| N0-vs-N2 |
8.474000E-01 |
| N1-vs-N2 |
7.229200E-01 |
|
|
